Engine Capital Management LP Cuts Stock Position in Acadia Healthcare Company, Inc. $ACHC

Engine Capital Management LP cut its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 87.3% in the fourth quarter, HoldingsChannel reports. The firm owned 328,833 shares of the company’s stock after selling 2,256,741 shares during the quarter. Acadia Healthcare accounts for 0.6% of Engine Capital Management LP’s portfolio, making the stock its 21st largest position. Engine Capital Management LP’s holdings in Acadia Healthcare were worth $4,666,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Capitolis Liquid Global Markets LLC purchased a new stake in Acadia Healthcare in the 4th quarter worth about $8,954,000. Boothbay Fund Management LLC raised its holdings in shares of Acadia Healthcare by 61.6% in the fourth quarter. Boothbay Fund Management LLC now owns 71,154 shares of the company’s stock valued at $1,010,000 after acquiring an additional 27,134 shares in the last quarter. Guggenheim Capital LLC raised its holdings in shares of Acadia Healthcare by 191.2% in the fourth quarter. Guggenheim Capital LLC now owns 63,693 shares of the company’s stock valued at $904,000 after acquiring an additional 41,824 shares in the last quarter. Schonfeld Strategic Advisors LLC raised its holdings in shares of Acadia Healthcare by 78.7% in the fourth quarter. Schonfeld Strategic Advisors LLC now owns 103,471 shares of the company’s stock valued at $1,468,000 after acquiring an additional 45,572 shares in the last quarter. Finally, AQR Capital Management LLC raised its holdings in shares of Acadia Healthcare by 72.8% in the fourth quarter. AQR Capital Management LLC now owns 272,670 shares of the company’s stock valued at $3,869,000 after acquiring an additional 114,868 shares in the last quarter.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on ACHC shares. Jefferies Financial Group upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their target price for the company from $24.50 to $30.00 in a research note on Wednesday, June 3rd. TD Cowen lifted their target price on Acadia Healthcare from $24.00 to $30.00 and gave the company a “buy” rating in a research note on Tuesday, April 28th. UBS Group lifted their target price on Acadia Healthcare from $27.00 to $31.00 and gave the company a “buy” rating in a research note on Friday, April 17th. Barclays lifted their target price on Acadia Healthcare from $20.00 to $25.00 and gave the company an “equal weight” rating in a research note on Thursday, April 30th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Acadia Healthcare in a research note on Friday, June 12th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have assigned a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $26.85.

Acadia Healthcare Price Performance

Shares of ACHC stock opened at $23.50 on Thursday. Acadia Healthcare Company, Inc. has a fifty-two week low of $11.43 and a fifty-two week high of $30.20. The firm has a market capitalization of $2.16 billion, a price-to-earnings ratio of -1.92, a PEG ratio of 8.34 and a beta of 0.69. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.71 and a current ratio of 1.71. The stock’s 50-day simple moving average is $25.53 and its 200-day simple moving average is $20.23.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share for the quarter, topping analysts’ consensus estimates of $0.28 by $0.09. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The business had revenue of $828.80 million for the quarter, compared to analyst estimates of $823.51 million. During the same quarter in the previous year, the firm earned $0.40 earnings per share. The company’s revenue was up 7.6% on a year-over-year basis. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. As a group, equities analysts forecast that Acadia Healthcare Company, Inc. will post 1.5 earnings per share for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.